BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: El Feghaly RE, Stauber JL, Tarr PI, Haslam DB. Intestinal inflammatory biomarkers and outcome in pediatric Clostridium difficile infections. J Pediatr 2013;163:1697-1704.e2. [PMID: 24011765 DOI: 10.1016/j.jpeds.2013.07.029] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Tougas SR, Lodha N, Vandermeer B, Lorenzetti DL, Tarr PI, Tarr GAM, Chui L, Vanderkooi OG, Freedman SB. Prevalence of Detection of Clostridioides difficile Among Asymptomatic Children: A Systematic Review and Meta-analysis. JAMA Pediatr 2021;:e212328. [PMID: 34338715 DOI: 10.1001/jamapediatrics.2021.2328] [Reference Citation Analysis]
2 Conrad MA, Kelsen JR. Clostridioides difficile Infection in Pediatric Inflammatory Bowel Disease: A Clinician's Dilemma. J Pediatric Infect Dis Soc 2021:piab069. [PMID: 34343321 DOI: 10.1093/jpids/piab069] [Reference Citation Analysis]
3 El Feghaly RE, Bangar H, Haslam DB. The molecular basis of Clostridium difficile disease and host response. Curr Opin Gastroenterol 2015;31:24-9. [PMID: 25394235 DOI: 10.1097/MOG.0000000000000131] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
4 Heffernan AJ, Denny KJ. Host Diagnostic Biomarkers of Infection in the ICU: Where Are We and Where Are We Going? Curr Infect Dis Rep 2021;23:4. [PMID: 33613126 DOI: 10.1007/s11908-021-00747-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
5 Hourigan SK, Sears CL, Oliva-Hemker M. Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:1020-5. [PMID: 26689599 DOI: 10.1097/MIB.0000000000000666] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
6 Jose S, Madan R. Neutrophil-mediated inflammation in the pathogenesis of Clostridium difficile infections. Anaerobe 2016;41:85-90. [PMID: 27063896 DOI: 10.1016/j.anaerobe.2016.04.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
7 Chen YS, Chen IB, Pham G, Shao TY, Bangar H, Way SS, Haslam DB. IL-17-producing γδ T cells protect against Clostridium difficile infection. J Clin Invest 2020;130:2377-90. [PMID: 31990686 DOI: 10.1172/JCI127242] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
8 Wojciechowski AL, Parameswaran GI, Mattappallil A, Mergenhagen KA. Corticosteroid use is associated with a reduced incidence of Clostridium difficile-associated diarrhea: a retrospective cohort study. Anaerobe 2014;30:27-9. [PMID: 25108272 DOI: 10.1016/j.anaerobe.2014.07.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
9 Lin H, Wang Q, Liu L, Chen Z, Das R, Zhao Y, Mao D, Luo Y. Colonization of Mice With Amoxicillin-Associated Klebsiella variicola Drives Inflammation via Th1 Induction and Treg Inhibition. Front Microbiol 2020;11:1256. [PMID: 32670220 DOI: 10.3389/fmicb.2020.01256] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Horrigan O, Jose S, Mukherjee A, Sharma D, Huber A, Madan R. Leptin Receptor q223r Polymorphism Influences Clostridioides difficile Infection-Induced Neutrophil CXCR2 Expression in an Interleukin-1β Dependent Manner. Front Cell Infect Microbiol 2021;11:619192. [PMID: 33718269 DOI: 10.3389/fcimb.2021.619192] [Reference Citation Analysis]
11 Daquigan N, Seekatz AM, Greathouse KL, Young VB, White JR. High-resolution profiling of the gut microbiome reveals the extent of Clostridium difficile burden. NPJ Biofilms Microbiomes 2017;3:35. [PMID: 29214047 DOI: 10.1038/s41522-017-0043-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 5.6] [Reference Citation Analysis]
12 Alghounaim M, Longtin Y, Gonzales M, Merckx J, Winters N, Quach C. Clostridium difficile Infections in Children: Impact of the Diagnostic Method on Infection Rates. Infect Control Hosp Epidemiol 2016;37:1087-93. [DOI: 10.1017/ice.2016.123] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
13 Young-xu Y, Kakkar R, Mills P, Wegner CD. Effect of Colchicine on Clostridium Difficile Infection Incidence, Recurrence, and Severity. Infectious Diseases in Clinical Practice 2015;23:141-7. [DOI: 10.1097/ipc.0000000000000246] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Saleh MM, Frisbee AL, Leslie JL, Buonomo EL, Cowardin CA, Ma JZ, Simpson ME, Scully KW, Abhyankar MM, Petri WA Jr. Colitis-Induced Th17 Cells Increase the Risk for Severe Subsequent Clostridium difficile Infection. Cell Host Microbe 2019;25:756-765.e5. [PMID: 31003940 DOI: 10.1016/j.chom.2019.03.003] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 13.0] [Reference Citation Analysis]
15 Saleh MM, Petri WA Jr. Type 3 Immunity during Clostridioides difficile Infection: Too Much of a Good Thing? Infect Immun 2019;88:e00306-19. [PMID: 31570564 DOI: 10.1128/IAI.00306-19] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
16 Abhyankar MM, Ma JZ, Scully KW, Nafziger AJ, Frisbee AL, Saleh MM, Madden GR, Hays AR, Poulter M, Petri WA Jr. Immune Profiling To Predict Outcome of Clostridioides difficile Infection. mBio 2020;11:e00905-20. [PMID: 32457246 DOI: 10.1128/mBio.00905-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, Loo V, Shaklee Sammons J, Sandora TJ, Wilcox MH. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018;66:e1-e48. [PMID: 29462280 DOI: 10.1093/cid/cix1085] [Cited by in Crossref: 718] [Cited by in F6Publishing: 613] [Article Influence: 239.3] [Reference Citation Analysis]
18 Nicholson MR, Osgood CL, Acra SA, Edwards KM. Clostridium difficile infection in the pediatric transplant patient. Pediatr Transplant 2015;19:792-8. [PMID: 26403484 DOI: 10.1111/petr.12578] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
19 Stauber J, Shaikh N, Ordiz MI, Tarr PI, Manary MJ. Droplet digital PCR quantifies host inflammatory transcripts in feces reliably and reproducibly. Cell Immunol. 2016;303:43-49. [PMID: 27063479 DOI: 10.1016/j.cellimm.2016.03.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
20 Schwenk HT, Pollock NR, Vaughan-Malloy AM. Pediatric Clostridioides difficile Infection: Diagnosis and Diagnostic Stewardship. J Pediatric Infect Dis Soc 2021;10:S16-21. [PMID: 34791395 DOI: 10.1093/jpids/piab054] [Reference Citation Analysis]
21 Nicholson MR, Thomsen IP, Edwards KM. Controversies Surrounding Clostridium difficile Infection in Infants and Young Children. Children (Basel) 2014;1:40-7. [PMID: 27417466 DOI: 10.3390/children1010040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
22 Schlaberg R, Barrett A, Edes K, Graves M, Paul L, Rychert J, Lopansri BK, Leung DT. Fecal Host Transcriptomics for Non-Invasive Human Mucosal Immune Profiling: Proof of Concept in Clostridium Difficile Infection. Pathog Immun 2018;3:164-80. [PMID: 30283823 DOI: 10.20411/pai.v3i2.250] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
23 Wang L, Cao J, Li C, Zhang L. Chemokine CXCL13 expression was up-regulated in Clostridium difficile infection. Cytokine 2016;88:232-40. [DOI: 10.1016/j.cyto.2016.09.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
24 Golizeh M, Winter K, Roussel L, Landekic M, Langelier M, Loo VG, Ndao M, Vinh DC. Fecal host biomarkers predicting severity of Clostridioides difficile infection. JCI Insight 2021;6:142976. [PMID: 33232301 DOI: 10.1172/jci.insight.142976] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Permpalung N, Upala S, Sanguankeo A, Sornprom S. Association between NSAIDs and Clostridium difficile-Associated Diarrhea: A Systematic Review and Meta-Analysis. Can J Gastroenterol Hepatol 2016;2016:7431838. [PMID: 27446866 DOI: 10.1155/2016/7431838] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
26 Lees EA, Carrol ED, Ellaby NAF, Roberts P, Corless CE, Lenzi L, Darby A, O'Brien SJ, Cunliffe NA, Turner MA, Miyajima F, Pirmohamed M. Characterization of Circulating Clostridium difficile Strains, Host Response and Intestinal Microbiome in Hospitalized Children With Diarrhea. Pediatr Infect Dis J 2020;39:221-8. [PMID: 31876614 DOI: 10.1097/INF.0000000000002559] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
27 Cowardin CA, Buonomo EL, Saleh MM, Wilson MG, Burgess SL, Kuehne SA, Schwan C, Eichhoff AM, Koch-Nolte F, Lyras D, Aktories K, Minton NP, Petri WA Jr. The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia. Nat Microbiol 2016;1:16108. [PMID: 27573114 DOI: 10.1038/nmicrobiol.2016.108] [Cited by in Crossref: 89] [Cited by in F6Publishing: 83] [Article Influence: 14.8] [Reference Citation Analysis]
28 Buonomo EL, Petri WA Jr. The microbiota and immune response during Clostridium difficile infection. Anaerobe 2016;41:79-84. [PMID: 27212111 DOI: 10.1016/j.anaerobe.2016.05.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
29 Leibowitz J, Soma VL, Rosen L, Ginocchio CC, Rubin LG. Similar Proportions of Stool Specimens From Hospitalized Children With and Without Diarrhea Test Positive for Clostridium difficile. Pediatric Infectious Disease Journal 2015;34:261-6. [DOI: 10.1097/inf.0000000000000556] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 4.4] [Reference Citation Analysis]
30 Antonara S, Leber AL. Diagnosis of Clostridium difficile Infections in Children. J Clin Microbiol 2016;54:1425-33. [PMID: 26912759 DOI: 10.1128/JCM.03014-15] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
31 Lees EA, Miyajima F, Pirmohamed M, Carrol ED. The role of Clostridium difficile in the paediatric and neonatal gut - a narrative review. Eur J Clin Microbiol Infect Dis 2016;35:1047-57. [PMID: 27107991 DOI: 10.1007/s10096-016-2639-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
32 Htwe P, Aung H, Kywe B, Niang PT, Oo TS, Monhandas S, Kelly L, Goldman DL. Endotoxin Acts Synergistically With Clostridioides difficile Toxin B to Increase Interleukin 1β Production: A Potential Role for the Intestinal Biome in Modifying the Severity of C. difficile Colitis. J Infect Dis 2021;224:1556-65. [PMID: 33780547 DOI: 10.1093/infdis/jiab165] [Reference Citation Analysis]
33 Bonacorsi S, Visseaux B, Bouzid D, Pareja J, Rao SN, Manissero D, Hansen G, Vila J. Systematic Review on the Correlation of Quantitative PCR Cycle Threshold Values of Gastrointestinal Pathogens With Patient Clinical Presentation and Outcomes. Front Med (Lausanne) 2021;8:711809. [PMID: 34631732 DOI: 10.3389/fmed.2021.711809] [Reference Citation Analysis]
34 Anikst VE, Gaur RL, Schroeder LF, Banaei N. Organism burden, toxin concentration, and lactoferrin concentration do not distinguish between clinically significant and nonsignificant diarrhea in patients with Clostridium difficile. Diagnostic Microbiology and Infectious Disease 2016;84:343-6. [DOI: 10.1016/j.diagmicrobio.2015.11.022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
35 Dow DE, Seed PC. Clostridium difficile cure with fecal microbiota transplantation in a child with Pompe disease: a case report. J Med Case Rep 2018;12:112. [PMID: 29703246 DOI: 10.1186/s13256-018-1659-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Minotti C, Barbieri E, Giaquinto C, Donà D. Vancomycin Use in Children and Neonates across Three Decades: A Bibliometric Analysis of the Top-Cited Articles. Pathogens 2021;10:1343. [PMID: 34684291 DOI: 10.3390/pathogens10101343] [Reference Citation Analysis]
37 Buonomo EL, Cowardin CA, Wilson MG, Saleh MM, Pramoonjago P, Petri WA Jr. Microbiota-Regulated IL-25 Increases Eosinophil Number to Provide Protection during Clostridium difficile Infection. Cell Rep 2016;16:432-43. [PMID: 27346351 DOI: 10.1016/j.celrep.2016.06.007] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 11.2] [Reference Citation Analysis]
38 Yacyshyn MB, Reddy TN, Plageman LR, Wu J, Hollar AR, Yacyshyn BR. Clostridium difficile recurrence is characterized by pro-inflammatory peripheral blood mononuclear cell (PBMC) phenotype. J Med Microbiol 2014;63:1260-73. [PMID: 25001105 DOI: 10.1099/jmm.0.075382-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
39 Usacheva EA, Jin JP, Peterson LR. Host response to Clostridium difficile infection: Diagnostics and detection. J Glob Antimicrob Resist 2016;7:93-101. [PMID: 27693863 DOI: 10.1016/j.jgar.2016.08.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
40 Takahashi MK, Tan X, Dy AJ, Braff D, Akana RT, Furuta Y, Donghia N, Ananthakrishnan A, Collins JJ. A low-cost paper-based synthetic biology platform for analyzing gut microbiota and host biomarkers. Nat Commun 2018;9:3347. [PMID: 30131493 DOI: 10.1038/s41467-018-05864-4] [Cited by in Crossref: 110] [Cited by in F6Publishing: 85] [Article Influence: 27.5] [Reference Citation Analysis]
41 Bassères E, Endres BT, Khaleduzzaman M, Miraftabi F, Alam MJ, Vickers RJ, Garey KW. Impact on toxin production and cell morphology in Clostridium difficile by ridinilazole (SMT19969), a novel treatment for C. difficile infection. J Antimicrob Chemother 2016;71:1245-51. [PMID: 26895772 DOI: 10.1093/jac/dkv498] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
42 Cowardin CA, Petri WA Jr. Host recognition of Clostridium difficile and the innate immune response. Anaerobe 2014;30:205-9. [PMID: 25223264 DOI: 10.1016/j.anaerobe.2014.08.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
43 Zhou Y, Wylie KM, El Feghaly RE, Mihindukulasuriya KA, Elward A, Haslam DB, Storch GA, Weinstock GM. Metagenomic Approach for Identification of the Pathogens Associated with Diarrhea in Stool Specimens. J Clin Microbiol 2016;54:368-75. [PMID: 26637379 DOI: 10.1128/JCM.01965-15] [Cited by in Crossref: 46] [Cited by in F6Publishing: 30] [Article Influence: 6.6] [Reference Citation Analysis]
44 Kelly CP, Chen X, Williams D, Xu H, Cuddemi CA, Daugherty K, Barrett C, Miller M, Foussadier A, Lantz A, Banz A, Pollock NR. Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea. Clin Infect Dis 2020;70:1083-93. [PMID: 31211839 DOI: 10.1093/cid/ciz330] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]